Medical research

Revealing a novel mode of action for an osteoporosis drug

(Medical Xpress)—Raloxifene is a U.S. Food and Drug Administration (FDA)-approved treatment for decreasing fracture risk in osteoporosis. While raloxifene is as effective at reducing fracture risk as other current treatments, ...

Neuroscience

Molecular basis of age-related memory loss explained

From telephone numbers to foreign vocabulary, our brains hold a seemingly endless supply of information. However, as we are getting older, our ability to learn and remember new things declines. A team of scientists around ...

Oncology & Cancer

Seemingly invincible cancers stem cells reveal a weakness

Metastatic cancer cells, which can migrate from primary tumors to seed new malignancies, have thus far been resistant to the current arsenal of anticancer drugs. Now, however, researchers at Whitehead Institute have identified ...

Oncology & Cancer

Fighting cancer with dietary changes

Calorie restriction, a kind of dieting in which food intake is decreased by a certain percentage, has been touted as way to help people live longer. New research suggests that there may be other benefits, including improving ...

Medical research

Research identifies compounds that control hemorrhagic viruses

People fear diseases such as Ebola, Marburg, Lassa fever, rabies and HIV for good reason; they have high mortality rates and few, if any, possible treatments. As many as 90 percent of people who contract Ebola, for instance, ...

page 24 from 32